Medical Devices
HeartBeam Inc. Receives FDA Clearance for Innovative Cable-Free ECG System
HeartBeam Inc. has achieved FDA 510(k) clearance for its pioneering, credit card-sized, cable-free ECG system, enhancing remote arrhythmia detection and cardiac care accessibility.
HeartBeam Inc. Strengthens Cardiac Care Innovation with New Patents
HeartBeam Inc. has secured two new U.S. patents for its 3D ECG and cardiac monitoring technology, marking a significant advancement in remote cardiac diagnostics and enhancing the company's intellectual property portfolio.
PolyPid Secures $26.7 Million Funding, Advances Toward FDA Approval with Promising D-PLEX₁₀₀
PolyPid Ltd. has secured $26.7 million in funding following successful Phase 3 trial results for its surgical infection prevention technology, D-PLEX₁₀₀, positioning the company for FDA approval and significant market impact.
HeartBeam Inc. Advances Cardiac Monitoring with New Patents
HeartBeam Inc. has secured two new U.S. patents for its innovative 3D ECG and cardiac monitoring technologies, marking a significant step forward in remote cardiac diagnostics and patient care.
HeartBeam Inc. and AccurKardia Collaborate to Enhance Remote Cardiac Monitoring
HeartBeam Inc. partners with AccurKardia to integrate FDA-cleared ECG analysis software into its portable cardiac monitoring device, aiming to improve arrhythmia detection and patient care accessibility.
HeartBeam Inc. Pioneers Cable-Free ECG System for At-Home Cardiac Monitoring
HeartBeam Inc. introduces a revolutionary cable-free system for synthesizing 12-lead ECGs from 3D signals, enabling patients to record their symptoms anywhere, potentially transforming cardiac care by facilitating early detection and timely intervention.
HeartBeam Inc.'s VALID-ECG Study Confirms High Diagnostic Accuracy of Synthesized 12-Lead ECG
HeartBeam Inc.'s innovative credit card-sized ECG device has shown a 93.4% diagnostic agreement with standard ECGs in the VALID-ECG study, marking a significant step towards portable cardiac care solutions.
HeartBeam Inc. Advances Toward Commercialization with Promising Q1 2025 Results
HeartBeam Inc. reports significant progress in its Q1 2025 results, including successful clinical endpoints in its VALID-ECG study and strategic collaborations, marking a pivotal step towards the commercialization of its innovative cardiac care technology.
HIGHER Corporation Recognized as 'Baby Unicorn' for Innovative Medical Devices
HIGHER Corporation's selection as a 'Baby Unicorn' underscores its potential in the global medical device market, with its HILO WAVE® product leading the charge in innovative skin regeneration technology.
Glucotrack Innovates Diabetes Management with Implantable Glucose Monitor
Glucotrack Inc. is revolutionizing diabetes care with its fully implantable continuous blood glucose monitoring system, addressing key patient concerns and setting new standards for accuracy and convenience.
Nutriband Inc. Secures U.S. Patent for Innovative Abuse-Deterrent Transdermal Technology
Nutriband Inc. has been granted a U.S. patent for its Aversa(TM) technology, marking a significant step forward in the fight against drug abuse and misuse with its abuse-deterrent transdermal products.
United Health Products Awaits FDA Decision on Hemostatic Gauze Clinical Study
United Health Products, Inc. is in the process of addressing FDA findings related to a BIMO audit for its hemostatic gauze product, CelluSTAT, aiming to expedite patient enrollment upon approval.
Nutriband Inc. Advances Abuse-Deterrent Buprenorphine Therapy with AVERSA Technology
Nutriband Inc. is pioneering a novel transdermal delivery system for buprenorphine, aiming to address the opioid epidemic with safer treatment options, potentially revolutionizing pain and addiction therapies.
Vensana Capital Strengthens Team with Key Appointments in Medical Technology Investment
Vensana Capital enhances its leadership team by appointing Maria Berkman as Partner and Ross (Rusty) Segan as Venture Partner, signaling a strategic move to bolster its expertise in medical technology investments.
Nutriband Inc.'s AVERSA Technology Poised for FDA Approval with Significant Market Potential
Nutriband Inc.'s innovative AVERSA abuse-deterrent patch technology, targeting the misuse of transdermal patches like fentanyl, is on its way to FDA approval, with an estimated annual market potential of $800 million.
Lorati Unveils NanoClay Paste: A Natural Revolution in Wound Care
Lorati Company Limited introduces NanoClay Paste, a natural, mineral-based treatment offering fast and effective healing for chronic wounds and skin infections, marking a significant advancement in non-invasive medical solutions.
Inspira Technologies Receives Buy Rating with $2 Price Target, Signaling Major Medical Technology Breakthrough
Litchfield Hills Research initiated coverage of Inspira Technologies with a Buy rating and $2 price target, highlighting the company's innovative respiratory support technology that could revolutionize critical care treatment by offering an alternative to traditional mechanical ventilation.
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control
Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.
AI-Powered Exoskeleton Restores Mobility for Wheelchair Users
A new AI-driven exoskeleton technology is transforming the lives of individuals with mobility impairments, offering unprecedented freedom and social interaction for wheelchair users through advanced technological innovation.
Glucotrack Unveils Revolutionary Continuous Blood Glucose Monitor Technology at Upcoming Webinar
Glucotrack is set to showcase its innovative Continuous Blood Glucose Monitor (CBGM) technology, offering a potential breakthrough in diabetes management with longer-lasting, real-time monitoring capabilities.
Innovative Swallowable Pill Promises Real-Time Gut Health Monitoring
A new medical technology offers groundbreaking potential for tracking gut inflammation in real-time through a swallowable pill, which could revolutionize diagnostic approaches for gastrointestinal disorders.
Nutriband Seeks to Revolutionize Transdermal Pain Management Through Innovative Abuse-Deterrent Technology
Nutriband is developing a groundbreaking transdermal drug delivery platform aimed at addressing pain management challenges in the wake of the opioid crisis, focusing on creating safer, more accessible opioid therapies.
Intelligent Bio Solutions Advances Non-Invasive Drug Testing Technology for U.S. Market
Intelligent Bio Solutions is progressing toward FDA clearance for a groundbreaking fingerprint-based drug screening system with 94.1% accuracy, positioning the company for potential expansion across safety-critical industries in the United States.
Nutriband Advances Opioid Patch Technology with Potential Abuse-Deterrent Solution
Nutriband is making significant progress toward commercializing its AVERSA Fentanyl technology, partnering with Kindeva Drug Delivery to develop a potentially groundbreaking opioid pain patch with abuse-deterrent properties.
SeaStar Medical Advances Organ-Saving Therapies for Critically Ill Patients
SeaStar Medical is developing innovative medical devices targeting acute kidney injury, leveraging FDA Breakthrough Device Status to potentially transform treatment for critically ill patients across multiple serious conditions.
Turner MedTech Expands Manufacturing Capabilities to Improve MRI Patient Positioning
Turner MedTech is scaling up manufacturing for its KyphoLift patient positioning system, addressing critical needs in medical imaging for patients with mobility challenges and complex spinal conditions. The expansion aims to enhance diagnostic precision and patient comfort in MRI procedures.
MDPen Launches Corrective Microneedling™: Advanced Skin Rejuvenation Technology
MDPen introduces a cutting-edge microneedling technique that creates up to 324,000 microchannels per minute, offering comprehensive skin rejuvenation solutions for practitioners and patients across multiple skin concerns.
Canadian Firms Unveil Rapid Drug Residue Detection Device to Enhance Public Safety
Kaimi Biotech and Scenesafe partner to introduce Unow™, a portable testing device capable of quickly identifying trace drug residues across multiple sectors in Canada. The technology aims to improve safety protocols in law enforcement, healthcare, and property management.
Nutriband Expands Pharma Footprint with Strategic Partnerships
Nutriband Inc. strengthens its market position through strategic alliances with Charlotte FC and Kindeva Drug Delivery, focusing on its innovative abuse-deterrent transdermal drug delivery technology.
HeartBeam Advances Cardiac Care Technology with FDA Milestone and Strategic Partnerships
Medical technology company HeartBeam achieved significant progress in Q1 2025, completing a pivotal study for its 12-lead ECG synthesis software and expanding strategic partnerships while raising crucial funding for commercialization.